AGILENT TECHNOLOGIES, INC. A
NYSE · XNYS · stock · Laboratory Analytical Instruments
Chart by TradingView
5/9
Piotroski F — financial health
2.26
Altman Z″ — distress risk · grey
21.6%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $6.9B | $1.3B | — | $1.2B | -$226.0M |
| 2024 | $6.5B | $1.3B | — | $1.4B | -$305.0M |
| 2023 | $6.8B | $1.2B | — | $1.5B | -$327.0M |
| 2022 | $6.8B | $1.3B | — | $1.0B | $5.3B |
| 2021 | $6.3B | $1.2B | — | $1.3B | $5.4B |
| 2020 | $5.3B | $719.0M | — | $802.0M | $4.9B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.26 (grey)
- Working capital / assets 0.177
- Retained earnings / assets 0.109
- EBIT / assets 0.116
- Equity / liabilities -0.038
Source: SEC EDGAR filings · CIK 0001090872 · as of 2025-10-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.